207
Views
3
CrossRef citations to date
0
Altmetric
Original Research

Association Between Vitamin D Level and Respiratory Symptoms in Patients with Stable Chronic Obstructive Pulmonary Disease

, , ORCID Icon, , ORCID Icon, , , ORCID Icon & ORCID Icon show all
Pages 579-590 | Published online: 17 Mar 2022

References

  • GBD 2015 Chronic Respiratory Disease Collaborators. Global, regional, and national deaths, prevalence, disability-adjusted life years, and years lived with disability for chronic obstructive pulmonary disease and asthma, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet Respir Med. 2017;5: 691–706.
  • World Health Organization. Projections of mortality and causes of death, 2016 and 2060. Available from: https://www.who.int/healthinfo/global_burden_disease/projections_method.pdf. Accessed February 26, 2022.
  • Barnes P, Celli B. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. doi:10.1183/09031936.00128008
  • Kim V, Criner GJ. The chronic bronchitis phenotype in COPD: features and implications. Curr Opin Pulm Med. 2015;21(2):133. doi:10.1097/MCP.0000000000000145
  • O’donnell DE, Lam M, Webb KA. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;158(5):1557–1565. doi:10.1164/ajrccm.158.5.9804004
  • Global initiative for chronic obstructive lung disease global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease; 2021. Available from: http://www.goldcopd.org. Accessed February 15, 2022.
  • Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013;5(7):2502–2521. doi:10.3390/nu5072502
  • Rahman A, Hershey S, Ahmed S, Nibbelink K, Simpson RU. Heart extracellular matrix gene expression profile in the vitamin D receptor knockout mice. J Steroid Biochem Mol Biol. 2007;103(3–5):416–419. doi:10.1016/j.jsbmb.2006.12.081
  • Greiller CL, Martineau AR. Modulation of the immune response to respiratory viruses by vitamin D. Nutrients. 2015;7(6):4240–4270. doi:10.3390/nu7064240
  • Greiller CL, Suri R, Jolliffe DA, et al. Vitamin D attenuates rhinovirus-induced expression of intercellular adhesion molecule-1 (ICAM-1) and platelet-activating factor receptor (PAFR) in respiratory epithelial cells. J Steroid Biochem Mol Biol. 2019;187:152–159. doi:10.1016/j.jsbmb.2018.11.013
  • Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134(6):1129–1140. doi:10.1017/S0950268806007175
  • Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab. 2010;95(2):471–478. doi:10.1210/jc.2009-1773
  • Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266–281. doi:10.1056/NEJMra070553
  • Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the third national health and nutrition examination survey. Chest. 2005;128(6):3792–3798. doi:10.1378/chest.128.6.3792
  • Berg I, Hanson C, Sayles H, et al. Vitamin D, vitamin D binding protein, lung function and structure in COPD. Respir Med. 2013;107(10):1578–1588. doi:10.1016/j.rmed.2013.05.010
  • Burkes RM, Ceppe AS, Doerschuk CM, et al. Associations among 25-hydroxyvitamin d levels, lung function, and exacerbation outcomes in COPD: an analysis of the spiromics cohort. Chest. 2020;157(4):856–865. doi:10.1016/j.chest.2019.11.047
  • Ghosh AJ, Moll M, Hayden LP, Bon J, Regan E, Hersh CP. Vitamin D deficiency is associated with respiratory symptoms and airway wall thickening in smokers with and without COPD: a prospective cohort study. BMC Pulm Med. 2020;20(1):1–9. doi:10.1186/s12890-020-1148-4
  • Burkes RM, Couper DJ, Barjaktarevic IZ, et al. Age-dependent associations between 25-hydroxy vitamin D levels and COPD symptoms: analysis of SPIROMICS. J COPD Foundation. 2021;8(2):277. doi:10.15326/jcopdf.2020.0180
  • Malinovschi A, Masoero M, Bellocchia M, et al. Severe vitamin D deficiency is associated with frequent exacerbations and hospitalization in COPD patients. Respir Res. 2014;15(1):131. doi:10.1186/s12931-014-0131-0
  • Mekov E, Slavova Y, Tsakova A, et al. Vitamin D Deficiency and Insufficiency in Hospitalized COPD Patients. PLoS One. 2015;10(6):e0129080. doi:10.1371/journal.pone.0129080
  • Ferrari R, Caram LM, Tanni SE, Godoy I, de Paiva SAR. The relationship between Vitamin D status and exacerbation in COPD patients–a literature review. Respir Med. 2018;139:34–38. doi:10.1016/j.rmed.2018.04.012
  • Herr C, Greulich T, Koczulla RA, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res. 2011;12(1):31. doi:10.1186/1465-9921-12-31
  • Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D to prevent exacerbations of COPD: systematic review and meta-analysis of individual participant data from randomised controlled trials. Thorax. 2019;74(4):337–345. doi:10.1136/thoraxjnl-2018-212092
  • Rodriguez-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000;117(5, Supplement 2):398S–401S. doi:10.1378/chest.117.5_suppl_2.398S
  • Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
  • American Thoracic Society. Single-breath carbon monoxide diffusing capacity (transfer factor). recommendations for a standard technique–1995 update. Am J Respir Crit Care Med. 1995;152(6 Pt 1):2185–2198. doi:10.1164/ajrccm.152.6.8520796
  • Choi JK, Paek D, Lee JO. Normal predictive values of spirometry in Korean population. Tuberc Respir Dis. 2005;58(3):230–242. doi:10.4046/trd.2005.58.3.230
  • Park J, Choi I, Park K. Normal predicted standards of single breath carbon monoxide diffusing capacity of lung in healthy nonsmoking adults. Korean J Intern Med. 1985;28:176–183.
  • Pellegrino R, Viegi G, Brusasco V, et al. Interpretative strategies for lung function tests. Eur Respir J. 2005;26(5):948–968. doi:10.1183/09031936.05.00035205
  • Kim HJ, Oh Y-M. The diagnosis of chronic obstructive pulmonary disease according to current guidelines. J Korean Med Assoc. 2018;61(9):539–544. doi:10.5124/jkma.2018.61.9.539
  • Hwang YI, Jung KS, Lim SY, Lee YS, Kwon NH. A validation study for the Korean version of chronic obstructive pulmonary disease assessment test (CAT). Tuberc Respir Dis. 2013;74(6):256–263. doi:10.4046/trd.2013.74.6.256
  • Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.581
  • Jones P, Harding G, Berry P, Wiklund I, Chen W, Leidy NK. Development and first validation of the COPD assessment test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509
  • Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD assessment test (CAT™) scores. BMC Pulm Med. 2011;11:42. doi:10.1186/1471-2466-11-42
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. doi:10.1210/jc.2011-0385
  • Girgis CM, Clifton-Bligh RJ, Hamrick MW, Holick MF, Gunton JE. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev. 2013;34(1):33–83. doi:10.1210/er.2012-1012
  • Laaksi I, Ruohola JP, Tuohimaa P, et al. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am J Clin Nutr. 2007;86(3):714–717. doi:10.1093/ajcn/86.3.714
  • Jolliffe DA, Camargo CA, Sluyter JD, et al. Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diab Endocrinol. 2021;9(5):276–292. doi:10.1016/S2213-8587(21)00051-6